Variable | Univariate analysis | p value | Multivariate analysis | p value |
---|---|---|---|---|
Risk ratio (95% CI) | Risk ratio (95% CI) | |||
Male | 2.55 (1.47–4.65) | < 0.001 | 1.15 (0.39–3.44) | 0.807 |
Age | 1.10 (1.06–1.14) | < 0.001 | 1.08 (1.03–1.12) | < 0.001 |
PS 1, 2 | 6.58 (1.59–18.1) | 0.014 | 1.59 (0.34–5.29) | 0.514 |
Smoking history | 2.33 (1.35–4.19) | 0.002 | 1.49 (0.51–4.54) | 0.476 |
CCI | 1.34 (1.20–1.46) | < 0.001 | 1.20 (1.04–1.35) | 0.013 |
Incomplete MDT | 3.48 (1.92–6.32) | < 0.001 | 2.05 (1.00–4.02) | 0.049 |
CEA level | 1.07 (1.04–1.10) | < 0.001 | 1.06 (1.03–1.09) | 0.003 |
SUV max | 1.08(1.03–1.12) | 0.002 | 0.99 (0.92–1.07) | 0.844 |
Invasive component size | 1.07 (1.04–1.11) | < 0.001 | 1.04 (0.99–1.10) | 0.083 |
Non-adenocarcinoma | 2.48 (1.47–4.11) | < 0.001 | 0.91 (0.41–1.99) | 0.811 |
Lymphatic invasion | 1.17 (0.35–2.88) | 0.771 | ||
Vascular invasion | 1.68 (0.41–4.57) | 0.420 | ||
STAS | 1.08 (0.53–2.00) | 0.814 |